ArticleOncotarget2016

The afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling.

Laurence Booth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.